Bone Marrow and Peripheral Blood Mononuclear Cell Phenotype Changes after Cultivation and Autologous Infusion in Patients with Primary Biliary Cholangitis
Authors:
Open Access
- 1 September 2023
- journal article
- research article
- Vol. 49 (9) , 559-572
Abstract
Background: Primary biliary cholangitis (PBC) is a condition affecting the liver and immune system. In this study, the impact of autologous bone marrow-derived mononuclear cell (BM-MNC) transplantation on PBC patients was investigated. Methods: Sixteen eligible PBC patients participated at the National Scientific Medical Center in Astana, Kazakhstan, between 2017 and 2022, and BM-MNCs were harvested from their anterior iliac crest. After isolating and cultivating the BM-MNCs, they were infused back into the patient's peripheral veins. Changes in BM-MNC and peripheral blood mononuclear cell (PB-MNC) phenotypes were assessed before and after a 24-hour cultivation period and 72 hours post-transplantation. We monitored liver function parameters over 6-month intervals and conducted flow cytometry analysis to assess CD markers on BM-MNCs before and after cultivation and PB-MNCs before and after transplantation. Statistical analysis included the Friedman test for liver parameters and the Wilcoxon signed-rank test for BM-MNC and PB-MNC comparisons. Results: Our findings revealed significant reductions in liver function tests after multiple transplantations. Flow cytometry analysisbefore and after a24-hour culture and autologous BM-MNC infusion revealed the expansion of specific cell populations, with significant increases in CD3+, CD4+, CD16+, CD20+, CD25+, CD34+, CD105+, CD73+, & Scy;D117+, and CD34+populations, while CD4+25+, CD34+105+, and CD4+FOXP3+ populations decreased. Interestingly, a contradictory finding was observed with a decrease in bone marrow CD34+105+ cell lines (P=0.03) alongside an increase in peripheral CD34+105+ population (P=0.03). Conclusion: In summary, our study shows that BM-MNC transplantation in PBC patients leads to changes in immune cell populations and liver function. These findings suggest potential therapeutic applications of BM-MNC transplantation in managing PBC and offer insights into the dynamics of immune cells associated with this treatment approach.Keywords
This publication has 30 references indexed in Scilit:
- Activated cholangiocytes release macrophage-polarizing extracellular vesicles bearing the DAMP S100A11American Journal of Physiology-Cell Physiology, 2019
- Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary CholangitisGastroenterology Research and Practice, 2019
- Unhealthy Stem Cells: When Health Conditions Upset Stem Cell PropertiesCellular Physiology and Biochemistry, 2018
- Human intrahepatic regulatory T cells are functional, require IL‐2 from effector cells for survival, and are susceptible to Fas ligand‐mediated apoptosisHepatology, 2016
- A Case of Primary Biliary Cirrhosis That Progressed Rapidly after Treatment Involving RituximabCase Reports in Gastroenterology, 2013
- Biochemical and Immunologic Effects of Rituximab in Patients With Primary Biliary Cirrhosis and an Incomplete Response to Ursodeoxycholic AcidHepatology, 2011
- Extracellular Matrix Degradation and Remodeling in Development and DiseaseCold Spring Harbor Perspectives in Biology, 2011
- B cell depletion therapy exacerbates murine primary biliary cirrhosisHepatology, 2010
- A Model to Predict Survival in Patients With End–Stage Liver DiseaseHepatology, 2001
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973